Study of perioperative infection prevention drug protocol in transurethral prostate enucleation (HoLEP / TUEB):multi-center study

Study of perioperative infection prevention drug protocol in transurethral prostate enucleation (HoLEP / TUEB):multi-center study - Randomized study to determine optimal dosing period of antibiotics for prophylaxis in HoLEP/TUEB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016030

Enrollment

400

Registered

2015-01-01

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hypertrophy

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: patients performed HoLEP/TUEB for benign prostatic hypertrophy

Exclusion criteria

Exclusion criteria: excluding patients: underwent cystolithotripsy or underwent prostate biopsy simultaneously with preoperative pyuria indwelling urethral catheter

Design outcomes

Primary

Measure	Time frame
Frequency of febrile complications of postoperative within 30 days after the surgery	—

Countries

Japan

Contacts

Public ContactYoshikazu Togo

Hyogo College of Medicine Department of Urology

ytogo@hyo-med.ac.jp0798-45-6366

Outcome results